Ratings
0
Nobody has rated this yet. Be the first!
Works
2
A Phase Ib Study of Alpelisib (BYL719), a PI3Kα-Specific Inhibitor, with Letrozole in ER+/HER2- Metastatic Breast Cancer
Everolimus plus long-acting somatostatin analogs in thymic epithelial malignancies
